Faculty profile
Jong Lee
Back to facultyThis profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Calgary directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $1,093,950
Developing off-the-shelf CAR-double-negative T cell therapy against AML
CIHR · 2026 · Nominated PI
- $25,000
Developing off-the-shelf CAR-double-negative T cell therapy against AML
CIHR · 2026 · Nominated PI
- $120,000
Exercise to enhance adoptive (double-negative) T cell therapy for acute myeloid leukemia
CIHR · 2025 · Supervisor
Developing off-the-shelf CAR-double-negative T cell therapy against AML
Principal investigators: Lee, Jong Bok
Keywords: Acute Myeloid Leukemia; Adoptive T Cell Therapy; Allo-Hsct; Car-T Cell Therapy; Cd4-Car; Double-Negative T Cell Therapy; Immunotherapy; Logic-Gated Car
Developing off-the-shelf CAR-double-negative T cell therapy against AML
Principal investigators: Lee, Jong Bok
Keywords: Acute Myeloid Leukemia; Adoptive T Cell Therapy; Allo-Hsct; Car-T Cell Therapy; Cd4-Car; Double-Negative T Cell Therapy; Immunotherapy; Logic-Gated Car
Exercise to enhance adoptive (double-negative) T cell therapy for acute myeloid leukemia
Principal investigators: Lee, Heejae
Keywords: Acute Myeloid Leukemia; Adoptive Cellular Therapy; Cancer Immunotherapy; Double-Negative T Cells; Exercise Immunology; Exercise Oncology; Exercise Physiology
Investigating the therapeutic potential of CD4-targeted CAR-double negative T cells in acute myeloid leukemia
Principal investigators: Wang, Shanshan
Keywords: Acute Myeloid Leukemia; Adoptive Cellular Therapy; Animal Models; Cancer Immunology; Chimeric Antigen Receptor (Car)-T Cell Therapy; Double Negative T Cells; Immunotherapy; Novel Cancer Therapies
Investigating the therapeutic potential of CD4-targeted CAR double-negative T cells in acute myeloid leukemia
Principal investigators: Wang, Shanshan
Keywords: Ics Travel Awards
Allogeneic CD3+ CD4- CD8- double-negative T cell as a novel treatment for AML patients relapsed after allo-HSCT.
Principal investigators: Lee, Jong Bok
Keywords: Cancer
Developing novel chimeric antigen receptor double-negative T-cell therapy for acute myeloid leukemia
Principal investigators: Tin, Enoch
Keywords: Acute Myeloid Leukemia; Adoptive Cellular Therapy; Cancer Immunotherapy; Chimeric Antigen Receptor-T Cell Therapy; Double-Negative T Cells; Single-Cell Rna Sequencing; Xenograft Mouse Models
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
Principal investigators: Lee, Jong Bok
Keywords: Adoptive Cell Therapy; Allogeneic Hematopoietic Stem Cell Transplantation; Cancer; Cancer Immunotherapy; Double Negative T Cell; Graft-Versus-Host Disease; Graft-Versus-Leukemia; Immunology
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
Principal investigators: Lee, Jong Bok
Keywords: Cancer; Cancer Immunotherapy; Immunology
Canada Research Chair - Tier 2
Principal investigators: Lee, Jong Bok
Keywords: Crc
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.